Neutra Corp Financials

NTRR

Source SEC Filings (10-K/10-Q) Data as of Oct 31, 2023 Currency USD FYE January

This page shows Neutra Corp (NTRR) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 12 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI NTRR FY2023 2026-04-22

Neutra’s narrower losses come from cost cuts and external financing, not from a self-funding operation.

In FY2023, operating cash burn of -$153K was almost fully offset by financing inflow of $154K. Set against shares outstanding rising from 931.0M in FY2020 to 2.92B in FY2023, that pattern implies fresh capital replaced consumed cash rather than building a liquidity buffer or funding obvious balance-sheet expansion.

Revenue fell in FY2023, but gross margin widened to 51.9% from 33.9%, suggesting direct-cost relief or mix improvement even though the revenue base is still very small for its cost structure. Operating cash burn also improved from -$406K to -$153K, so the narrower loss was matched by a real reduction in cash use.

FY2023 ended with just $3K of cash and a current ratio of 0.03x, which is essentially no near-term cash cushion. With negative equity of -$809K and current liabilities of $809K, the balance sheet still leaves little room for routine operating friction, especially because current assets are not mostly cash.

Financial Health Signals

Financial health score pending refresh

We are recalculating Neutra Corp's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.

Altman Z-Score Distress

-332.28

Neutra Corp scores -332.28, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($584K) relative to total liabilities ($863K). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

2/5

Neutra Corp passes 2 of 5 computable financial strength tests (4 of the nine could not be computed from available data). No profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Interest Coverage At Risk

-4.8x

Neutra Corp earns $-4.8 in operating income for every $1 of interest expense (-$298K vs $62K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$68K

YoY-26.1%

Neutra Corp generated $68K in revenue in fiscal year 2023. This represents a decrease of 26.1% from the prior year.

EBITDA

-$219K

YoY+56.7%

Neutra Corp's EBITDA was -$219K in fiscal year 2023, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 56.7% from the prior year.

Net Income

N/A

EPS (Diluted)

N/A

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$3K

YoY-79.3%

10Y CAGR-31.5%

Neutra Corp held $3K in cash against $0 in long-term debt as of fiscal year 2023.

Dividends Per Share

N/A

Shares Outstanding

2.92B

YoY+32.2%

Neutra Corp had 2.92B shares outstanding in fiscal year 2023. This represents an increase of 32.2% from the prior year.

Margins & Returns

Gross Margin

51.9%

YoY+18.1pp

Neutra Corp's gross margin was 51.9% in fiscal year 2023, indicating the percentage of revenue retained after direct costs. This is up 18.1 percentage points from the prior year.

Operating Margin

-437.8%

YoY+196.5pp

Neutra Corp's operating margin was -437.8% in fiscal year 2023, reflecting core business profitability. This is up 196.5 percentage points from the prior year.

Net Margin

N/A

Return on Equity

N/A

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

NTRR Income Statement

Metric	FY23	FY22	FY21	FY20	FY19	FY18
Revenue	$68K-26.1%	$92K+849.9%	$10K+51.5%	$6K	N/A	N/A
Cost of Revenue	$33K-46.3%	$61K+41.7%	$43K	N/A	N/A	N/A
Gross Profit	$35K+13.3%	$31K+193.7%	-$33K-620.0%	$6K	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$228K-55.2%	$508K+22.6%	$415K+3.5%	$401K	N/A	$164K
Operating Income	-$298K+49.0%	-$584K-21.9%	-$479K-21.4%	-$394K	N/A	-$164K
Interest Expense	$62K+2.4%	$61K-50.2%	$122K-64.3%	$341K	N/A	$355K
Income Tax	$4K	N/A	$4K	$0	N/A	N/A
Net Income	N/A	-$633K-17.4%	-$539K	N/A	N/A	N/A
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22
Revenue	$1K-69.7%	$4K-26.0%	$6K-1.3%	$6K-74.7%	$23K-19.5%	$29K+200.5%	$10K-74.8%	$38K
Cost of Revenue	$722-72.7%	$3K-13.0%	$3K+2.5%	$3K-76.7%	$13K+1.8%	$12K+175.0%	$5K-52.9%	$10K
Gross Profit	$589-65.0%	$2K-40.0%	$3K-5.1%	$3K-72.3%	$11K-35.5%	$17K+223.0%	$5K-82.2%	$29K
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$43K-24.8%	$58K+13.9%	$51K+23.8%	$41K-11.7%	$46K-28.6%	$65K-13.9%	$76K-51.3%	$155K
Operating Income	-$53K+26.5%	-$72K-0.8%	-$71K-23.2%	-$58K+12.5%	-$66K+19.8%	-$82K+10.0%	-$91K+43.1%	-$161K
Interest Expense	$2K+7686.2%	$29-85.4%	$199-98.7%	$16K-1.2%	$16K+4.3%	$15K-4.2%	$16K+4.2%	$15K
Income Tax	N/A	$49-91.7%	$589	N/A	N/A	N/A	N/A	N/A
Net Income	-$55K+23.5%	-$72K+0.2%	-$72K	N/A	-$82K+16.0%	-$97K+9.1%	-$107K+39.0%	-$176K
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

NTRR Balance Sheet

Metric	FY23	FY22	FY21	FY20	FY19	FY18
Total Assets	$54K-63.3%	$147K-29.3%	$208K+55.6%	$134K+26.6%	$106K+13.8%	$93K
Current Assets	$24K-36.9%	$39K+89.4%	$20K-61.8%	$54K-49.3%	$106K+13.8%	$93K
Cash & Equivalents	$3K-79.3%	$15K-18.7%	$19K-62.3%	$50K	N/A	N/A
Inventory	$21K-3.0%	$22K	N/A	$2K	N/A	N/A
Accounts Receivable	N/A	N/A	$190	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$863K-31.1%	$1.3M0.0%	$1.3M+19.6%	$1.0M-18.8%	$1.3M+55.9%	$828K
Current Liabilities	$809K-33.3%	$1.2M+19.2%	$1.0M-2.9%	$1.0M-18.8%	$1.3M+55.9%	$828K
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$809K+26.8%	-$1.1M-5.8%	-$1.0M-14.3%	-$914K+22.8%	-$1.2M-61.2%	-$735K
Retained Earnings	-$11.5M-4.9%	-$11.0M-6.7%	-$10.3M-6.6%	-$9.7M-7.5%	-$9.0M-36.9%	-$6.6M

Metric	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22
Total Assets	$27K-27.1%	$37K-31.7%	$54K-28.0%	$75K-23.3%	$98K-30.9%	$142K-3.7%	$147K+12.5%	$131K
Current Assets	$19K-4.7%	$20K-16.8%	$24K-5.2%	$26K-10.6%	$29K-45.6%	$53K+36.7%	$39K+1355.0%	$3K
Cash & Equivalents	$692-39.0%	$1K-63.9%	$3K+59.4%	$2K+331.8%	$456-98.3%	$26K+73.3%	$15K+1338.3%	$1K
Inventory	$19K-3.1%	$19K-9.9%	$21K-10.5%	$24K-11.1%	$27K+6.8%	$25K+14.2%	$22K	N/A
Accounts Receivable	$98	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$963K+4.9%	$918K+6.3%	$863K+1.7%	$849K-37.7%	$1.4M+2.9%	$1.3M+5.6%	$1.3M-10.7%	$1.4M
Current Liabilities	$909K+5.2%	$864K+6.8%	$809K+6.5%	$760K-39.1%	$1.2M+3.4%	$1.2M-0.6%	$1.2M+5.1%	$1.2M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$936K-6.2%	-$881K-8.9%	-$809K-4.6%	-$774K+38.8%	-$1.3M-7.0%	-$1.2M-6.8%	-$1.1M+13.1%	-$1.3M
Retained Earnings	-$11.7M-0.5%	-$11.6M-0.6%	-$11.5M-0.6%	-$11.5M-2.5%	-$11.2M-0.7%	-$11.1M-1.0%	-$11.0M-1.0%	-$10.9M

NTRR Cash Flow Statement

Metric	FY23	FY22	FY21	FY20	FY19	FY18
Operating Cash Flow	-$153K+62.2%	-$406K+1.6%	-$412K-127.1%	-$182K+56.4%	-$417K-282.8%	-$109K
Capital Expenditures	N/A	$40K-79.5%	$196K	N/A	N/A	N/A
Free Cash Flow	N/A	-$446K+26.8%	-$609K	N/A	N/A	N/A
Investing Cash Flow	N/A	-$40K+79.5%	-$196K	N/A	N/A	N/A
Financing Cash Flow	$154K-63.6%	$424K-6.9%	$455K+26.8%	$359K-14.0%	$417K+282.8%	$109K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22
Operating Cash Flow	-$442+77.9%	-$2K+77.3%	-$9K-683.7%	$2K+106.5%	-$23K+40.2%	-$39K+58.1%	-$93K-74.8%	-$53K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-$53K
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0
Financing Cash Flow	$0	$0-100.0%	$10K	$0+100.0%	-$3K-105.3%	$50K-53.2%	$107K+327.2%	$25K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

NTRR Financial Ratios

Metric	FY23	FY22	FY21	FY20	FY19	FY18
Gross Margin	51.9%+18.1pp	33.9%+377.2pp	-343.3%-443.3pp	100.0%	N/A	N/A
Operating Margin	-437.8%+196.5pp	-634.2%+4307.1pp	-4941.3%+1223.6pp	-6164.9%	N/A	N/A
Net Margin	N/A	-687.9%+4875.2pp	-5563.0%	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	N/A	-429.6%-170.9pp	-258.7%	N/A	N/A	N/A
Current Ratio	0.030.0	0.03+0.0	0.02-0.0	0.05-0.0	0.08-0.0	0.11
Debt-to-Equity	-1.07+0.1	-1.13+0.1	-1.20-0.1	-1.15-0.1	-1.09+0.0	-1.13
FCF Margin	N/A	-484.5%+5800.9pp	-6285.4%	N/A	N/A	N/A

Metric	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22
Gross Margin	44.9%+6.0pp	38.9%-9.1pp	48.0%-1.9pp	49.9%+4.3pp	45.6%-11.4pp	57.0%+4.0pp	53.0%-21.9pp	74.9%
Operating Margin	-4022.0%-2362.6pp	-1659.4%-440.5pp	-1218.9%-242.6pp	-976.3%-693.8pp	-282.6%+1.1pp	-283.6%+663.0pp	-946.6%-528.0pp	-418.6%
Net Margin	-4194.2%-2533.0pp	-1661.2%-428.8pp	-1232.4%	N/A	-349.8%-14.2pp	-335.6%+773.9pp	-1109.5%-651.5pp	-457.9%
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	-204.1%-9.6pp	-194.5%-61.4pp	-133.1%	N/A	-83.5%-14.8pp	-68.7%+4.1pp	-72.8%+61.5pp	-134.3%
Current Ratio	0.020.0	0.020.0	0.030.0	0.03+0.0	0.02-0.0	0.04+0.0	0.03+0.0	0.00
Debt-to-Equity	-1.03+0.0	-1.04+0.0	-1.07+0.0	-1.10-0.0	-1.08+0.0	-1.12+0.0	-1.13-0.0	-1.10
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-138.1%

Note: Shareholder equity is negative (-$809K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.03), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Pharmagreen Biotech Inc PHBI

$571K

Aequus Pharmaceu AQSZF

$487K

Gold River Prod GRPS

$361K

Gelstat Corp GSAC

$1.1M

Vibe Growth VIBEF

$421K

Frequently Asked Questions

What is Neutra Corp's annual revenue?

Neutra Corp (NTRR) reported $68K in total revenue for fiscal year 2023. This represents a -26.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Neutra Corp's revenue growing?

Neutra Corp (NTRR) revenue declined by 26.1% year-over-year, from $92K to $68K in fiscal year 2023.

What is Neutra Corp's EBITDA?

Neutra Corp (NTRR) had EBITDA of -$219K in fiscal year 2023, measuring earnings before interest, taxes, depreciation, and amortization.

What is Neutra Corp's gross margin?

Neutra Corp (NTRR) had a gross margin of 51.9% in fiscal year 2023, indicating the percentage of revenue retained after direct costs of goods sold.

What is Neutra Corp's operating margin?

Neutra Corp (NTRR) had an operating margin of -437.8% in fiscal year 2023, reflecting the profitability of core business operations before interest and taxes.

What is Neutra Corp's operating cash flow?

Neutra Corp (NTRR) generated -$153K in operating cash flow during fiscal year 2023, representing cash generated from core business activities.

What are Neutra Corp's total assets?

Neutra Corp (NTRR) had $54K in total assets as of fiscal year 2023, including both current and long-term assets.

How many shares does Neutra Corp have outstanding?

Neutra Corp (NTRR) had 2.92B shares outstanding as of fiscal year 2023.

What is Neutra Corp's current ratio?

Neutra Corp (NTRR) had a current ratio of 0.03 as of fiscal year 2023, which is below 1.0, which may suggest potential liquidity concerns.

What is Neutra Corp's debt-to-equity ratio?

Neutra Corp (NTRR) had a debt-to-equity ratio of -1.07 as of fiscal year 2023, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Neutra Corp's cash runway?

Based on fiscal year 2023 data, Neutra Corp (NTRR) had $3K in cash against an annual operating cash burn of $153K. This gives an estimated cash runway of approximately 0 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Why is Neutra Corp's debt-to-equity ratio negative or unusual?

Neutra Corp (NTRR) has negative shareholder equity of -$809K as of fiscal year 2023, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is Neutra Corp's Altman Z-Score?

Neutra Corp (NTRR) has an Altman Z-Score of -332.28, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Neutra Corp's Piotroski F-Score?

Neutra Corp (NTRR) has a Piotroski F-Score of 2 out of 5 computable signals; 4 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Can Neutra Corp cover its interest payments?

Neutra Corp (NTRR) has an interest coverage ratio of -4.8x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.